Katsuaki Maehara Highlights TIM-3 as a Potential Target for Lung Adenocarcinoma Precancer Interception
Katsuaki Maehara, Director of Medical Education Colleagues, shared on X about a recent paper by Bo Zhu et al. published in Cancer Cell:
“Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.
TIM-3 as a potential target for LUAD precancer interception.”
Title: Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Authors: Bo Zhu, Pingjun Chen, Muhammad Aminu, Jian-Rong Li, Junya Fujimoto, Yanhua Tian, Lingzhi Hong, Hong Chen, Xin Hu, Chenyang Li, Natalie Vokes, Andre L. Moreira, Don L. Gibbons, Luisa M. Solis Soto, Edwin Roger Parra Cuentas, Ou Shi, Songhui Diao, Jie Ye, Frank R. Rojas, Eduardo Vilar, Anirban Maitra, Ken Chen, Nicolas Navin, Monique Nilsson, Beibei Huang, Simon Heeke, Jianhua Zhang, Cara L. Haymaker, Vamsidhar Velcheti, Daniel H. Sterman, Veena Kochat, William I. Padron, Ludmil B. Alexandrov, Zhubo Wei, Xiuning Le, Linghua Wang, Junya Fukuoka, J. Jack Lee, Ignacio I. Wistuba, Harvey I. Pass, Mark Davis, Samir Hannash, Chao Cheng, Steven Dubinett, Avrum Spira, Kunal Rai, Scott M. Lippman, P. Andrew Futreal, John V. Heymach, Alexandre Reuben, Jia Wu, Jianjun Zhang
More posts featuring Katsuaki Maehara.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023